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Background: The purpose of this study was to explore the effects of CYP2C19 gene polymorphisms and various
environmental factors and their interactions on the risk of esophageal squamous cell carcinoma (ESCC) in a Chinese
Han population.
Methods: A 1:2 frequency-matched case control study of 285 patients and 570 controls was conducted from
June 2010 to May 2011 in AnXi of Fujian province, China. Environmental factors were investigated using a
self-administered questionnaire and genotypes were determined using polymerase chain reaction restriction
fragment length polymorphism based methods. Unconditional logistic regression models were used for
statistical evaluation.
Results: Current or former smoking, consumption of pickled vegetables or hot beverages/food, having a first
degree relative with ESCC and history of reflux esophagitis were significantly associated with increased ESCC
risk, whereas tea drinking and consumption of fresh vegetables and fruits were significantly associated with
decreased risk. The CYP2C19*2 GA/AA genotype was significantly more prevalent in ESCC patients and
individuals with at least one copy of the CYP2C19*2 A allele had a 3.19-fold increased risk (adjusted 95%
confidence interval (CI): 2.21–4.61, P < 0.001) of ESCC compared with those without this allele. We found no
significant associations between CYP2C19*3 genotypes and ESCC. The Cyp2C19*2 polymorphism appeared to
have a multiplicative joint effect with tea drinking and hot beverage/food consumption (gene–tea drinking:
Pinteraction = 0.042; hot beverage/food consumption: Pinteraction = 6.98 × 10
−6) and an additive joint effect with
pickled vegetable consumption (interaction contrast ratio = 1.96, 95% CI: 0.12–3.80).
Conclusions: Our findings suggest that the CYP2C19*2 polymorphism plays an important role in the development
of ESCC in the Chinese population, modified by tea drinking and consumption of pickled vegetables or hot
beverages/food. Further studies are warranted to confirm our results.
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Esophageal squamous cell carcinoma (ESCC), a treatment
resistant cancer that can withstand a combination of sur-
gery, chemotherapy and radiotherapy [1], is the fourth
most commonly diagnosed cancer and the fourth leading
cause of cancer death in China. ESCC occurs through a
complex multistage process that may involve a combin-
ation of carcinogen exposure and genetic susceptibility.
Although smoking, alcohol drinking and prolonged use of
wood or charcoal as sources of fuel for cooking and heat-
ing (resulting in excessive smoke inhalation) have been
demonstrated as lifestyle factors that contribute to the
development of the disease [2-4], the DNA sequence
variations that confer an additional risk remain largely
unknown.
Cytochrome P450 2C19 (CYP2C19) is an important
phase I enzyme expressed abundantly in endothelial and
smooth muscle cells [5,6]. This enzyme is involved in the
metabolism of numerous therapeutic drugs and other xe-
nobiotics, including S-mephenytoin, omeprazole, diaze-
pam, proguanil, propranolol and certain antidepressants
[7]. CYP2C19 is also known to be involved in the detoxifi-
cation or inactivation of potential carcinogens [8] and the
bioactivation of certain environmental procarcinogens to
produce reactive DNA binding metabolites [9-11]. There-
fore, it is conceivable that CYP2C19 gene polymorphisms
may play a major role in inter-individual variability in drug
response, drug–drug and drug–xenobiotic interactions
and susceptibility to chemical-induced diseases.
Several polymorphisms of CYP2C19 are known to be
associated with reduced enzyme activity; however, most
cases are due to either CYP2C19*2, which is characterized
by a point mutation in exon 5 (681G→A, rs4244285), or
CYP2C19*3, which has a mutation in exon 4 (636G→A,
rs4986893) [12]. The presence of these alleles is consid-
ered to be sufficiently predictive for the phenotypes to be
inferred from them. Thus, individuals homozygous for
CYP2C19*2 or CYP2C19*3 are considered poor metaboli-
zers (PMs), whereas those with at least one CYP2C19*1
allele are classified as extensive metabolizers (EMs) [13].
Despite the biological plausibility of CYP2C19 functional
polymorphisms as modulators of susceptibility to cancer,
inconsistent findings have appeared in the literature; for
example, CYP2C19 PMs have a high incidence of stomach
cancer and lung cancer [14], but conversely have a low in-
cidence of bladder cancer [13]. Furthermore, the role of
these gene variants in ESCC has not been sufficiently well
investigated. Normally, Asian people have a higher inci-
dence of CYP2C19*3 than Caucasians [15,16] and the two
mutations CYP2C19*2 and CYP2C19*3 have been shown
to account for almost 100% of Asian PM alleles. There-
fore, it would be interesting to determine whether the high
incidence of ESCC is correlated with a greater frequency
of CYP2C19*3 or CYP2C19*2 in the Chinese population.In the present study, we hypothesized that individuals
with the CYP2C19*2 or CYP2C19*3 polymorphism may
have a higher risk of ESCC. We also speculated that there
should be a synergistic interaction between the effect of
environmental factors and that of the genetic variation in
the risk of ESCC.
Methods
Ethics statement
This study was approved by the institutional ethical com-
mittees of Fujian Medical University. Written informed
consent was obtained from all participants before their
participation in the study. All investigations performed in
this study were conducted in accordance with the guide-
lines of the 1975 Declaration of Helsinki.
Study population
A 1:2 frequency-matched case control study was per-
formed between June 2010 and May 2011 in AnXi, in the
Fujian Province of China. Two hundred and eighty-five
patients (168 males and 117 females; mean age 59.67 ±
9.83 years) were diagnosed with histologically confirmed
ESCC at AnXi Hospital. Five hundred and seventy cancer-
free control subjects (336 males and 234 females; mean
age 59.71 ± 9.84 years) were chosen randomly during the
same period from among local residents who underwent a
routine health check and were free from any known major
diseases. Controls were frequency matched with ESCC
patients according to sex, age (within 5 years), ethni-
city and area of residence. All subjects were genetically
unrelated ethnic Han Chinese from AnXi or the sur-
rounding regions.
Data collection
A standard questionnaire was administered to cases and
controls by specially trained interviewers. Questions cov-
ered demographic characteristics (e.g. age, education level,
job, marital status, sex), dietary habits, lifestyle habits such
as tobacco smoking and alcohol drinking, personal med-
ical history and family history of cancer. Non-smokers
were defined as individuals who had never smoked ciga-
rettes or who had smoked less than 100 cigarettes in life-
time. Ever tea drinking was defined as drinking at least 1
cup of green tea per week for more than 6 months. Ever
alcohol drinkers were subjects who had consumed any al-
coholic beverage, including beer, wine or distilled spirits,
at least once per week for a minimum of 6 months.
Genetic polymorphism genotyping
Blood samples were collected with a standard venepuncture
technique and ethylenediaminetetraacetic acid-containing
tubes. DNA was extracted from the blood cell pellet using
a Blood Genome DNA Extraction Kit (Takara Bio Inc.,
Ōtsu, Japan) and stored at −20°C. CYP2C19*2 (681G→A,
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types were determined using polymerase chain reaction
(PCR)-based restriction fragment length polymorphism.
PCR was performed with 25 μl of reaction mixture contain-
ing 100 ng of DNA, 0.1 mmol/l of each primer, 0.2 mmol/l
of deoxynucleoside triphosphate, 1.0 U of Taq DNA poly-
merase (Takara Bio Inc.), 1 × reaction buffer and 1.5 mmol/l
of MgCl2. The PCR profile comprised an initial melting
step for 2 min at 95°C, followed by 35 cycles of 30 s at 94°C,
30 s at 58°C and 30 s at 72°C and a final elongation step of
10 min at 72°C. The forward primer 5′-AATTACAACC
AGAGCTTGGC-3′ and the reverse primer 5′-TATCA
CTTTCCATAAAAGCAAG-3′ were used to detect the
CYP2C19*2 allele and the PCR products digested with
SmaI I (New England Biolabs, Ipswich, MA); the 168 bp
PCR products were cut into 117 and 51 bp fragments in
the wild type (WT) but not in CYP2C19*2. The forward
primer 5′-AAATTGTTTCCAATCATTTAGCT-3′ and
the reverse primer 5′-ACTTCAGGGCTTGGTCAATA-
3′ were used to detect the CYP2C19*3 allele and the PCR
products digested with BamHI (New England Biolabs);
the 271 bp PCR products were cut into 175 and 96 bp
fragments in the WT but not in CYP2C19*3. The digested
PCR products were analyzed on 3% agarose gels and
stained with ethidium bromide. Individuals who inherit
two mutant CYP2C19 alleles, whether of the same type
(*2/*2, *3/*3) or one of each (*2/*3) have a reduced cap-
acity to metabolize CYP2C19 substrates and are consid-
ered to be PMs. Individuals who are homozygous (*1/*1)
or heterozygous (*1/*2, *1/*3) for the WT CYP2C19*1 al-
lele have an effective enzyme for metabolizing CYP2C19
substrates and are EMs. For quality control, genotyping
was performed by laboratory personnel blinded to the case
control status and blank controls were included in each
plate. In addition, 10% of the samples were randomly se-
lected and genotyped a second time; the concordance
was 100%.
Statistical analysis
Differences in the distribution of demographic characteris-
tics and other risk factors for ESCC between patients and
controls were tested using the chi-square test for category
variables and Student’s t-test for continuous variables. Ad-
justed odds ratios (ORs) and their 95% confidence intervals
(CIs) were calculated to evaluate the associations of life-
style habits including smoking, alcohol/tea drinking and
diet with risk of ESCC. All models were adjusted for age as
a continuous variable, sex, education, income, occupation
(farmer/other), family history of cancer in first degree rela-
tives and other potential confounding factors. P values for
OR trends were calculated using the order of each risk fac-
tor category as a categorical variable.
A goodness of fit chi-square test was used to assess whether
the genotype distribution of CYP2C19 polymorphismswas in Hardy–Weinberg equilibrium among the control
subjects. Associations between CYP2C19 genotypes and
ESCC risk were evaluated using unconditional logistic
regression with adjustment for potential confounding fac-
tors including age, sex, education, income, occupation,
family history of cancer, consumption of vegetables, fruits
and meat, smoking status (no/yes), alcohol drinking (no/
yes) and tea drinking (no/yes).
Stratified analysis was used to explore potential gene–
environment interactions. We dichotomized the genetic
polymorphisms by grouping subjects into carriers and
non-carriers of the risk genotype. Similarly, environmen-
tal factors were dichotomized by appropriate grouping.
P values for multiplicative interactions were derived from
a cross-product term for gene and environmental expos-
ure introduced into a multiplicative model. Interaction
contrast ratio (ICR) was used to evaluate potential additive
interactions, as follows: ICR =OReg – ORe – ORg + 1,
where OReg is the OR for both the genotype and the
environmental exposure, ORe is the OR for the envir-
onment only and ORg is the OR for the genotype only.
For ICR > 0, we concluded that there was a positive addi-
tive interaction. Ninety-five percent CIs for ICRs were cal-
culated according to the method of Hosmer [17]; an ICR
was considered to be statistically significant at an alpha
level 0.05 if its 95% CI did not include zero.
All statistical analyses were performed using R software
(version 2.14.1; The R Foundation, Vienna, Austria). Two-
sided P values of < 0.05 were considered statistically
significant.Results
Characteristics of the study population
Associations between demographic characteristics and
ESCC are shown in Table 1. There were no statistically
significant differences between ESCC patients and con-
trols in terms of median age, sex or marital status (all P >
0.05), indicating that the frequency matching was ad-
equate. However, a greater proportion of farmers and a
lower education level were observed among the patients
compared with the controls (both P < 0.001).Associations between risk factors and ESCC risk
Table 2 shows adjusted associations between risk factors
and risk of ESCC. Increased ESCC risk was associated
with smoking, number of pack-years of cigarettes smoked,
consumption of pickled vegetables, consumption of hot
beverages/food, having a first degree relative with ESCC
and having a history of reflux esophagitis. Decreased risk
of ESCC was associated with tea drinking and consump-
tion of fresh vegetables and fruits. Thus, a total of six en-
vironmental factors were selected for evaluation of their
interactions with genetic variants in the risk of ESCC.





No % No %
Sex (Male) 0.00 1.000
Male 168 58.95 336 58.95
Female 117 41.05 234 41.05
Age group (years) 0.24 0.878
<50 97 34.02 191 33.51
≥50 188 65.96 379 66.49
Education level 13.62 0.001
Below middle school 146 51.23 223 39.12
middle school 105 36.84 284 49.82
High school or higher 34 11.93 63 11.05
Marital status 2.02 0.365
Marriage 259 90.88 518 90.88
Single 26 9.12 52 9.12
Job 22.54 2.5 × 10-6
Farmer 235 82.46 382 67.02




<1000 180 63.16 243 42.63
>1000 105 36.84 227 39.82
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Single nucleotide polymorphism (SNP) data, observed
allele frequencies and Hardy–Weinberg test results are
presented in Table 3. In the control group, the frequencies
of the CYP2C19*2 A and CYP2C19*3 A alleles were 0.335
and 0.054, respectively, and were in Hardy–Weinberg
equilibrium (both P > 0.05). On single allelic analysis, tests
for association between ESSC and the two SNPs showed a
significant difference only for CYP2C19*2 (G681A); the
association remained significant after multiple comparison
correction by permutation tests (P < 0.05; Table 3). The
findings for each of the two SNP genotypes according to
risk of ESCC are shown in Table 4 along with their ad-
justed ORs. The frequencies of the CYP2C19*2 GG, GA
and AA genotypes in the ESCC patients differed signifi-
cantly from those in the control group (χ2 = 43.56, P <
0.001, degrees of freedom= 2), with GA and AA being
more frequent in patients than in controls. The homozy-
gous mutant genotype (AA) of CYP2C19*3 was not detected
in any subject, patient or control, and the frequencies of
the CYP2C19*3 GG and GA genotypes did not differ sig-
nificantly between the controls and patients.
Unconditional logistic regression analysis was used
to evaluate associations between the genotypes of the
two CYP2C19 polymorphisms and risk of ESCC. Afteradjustment for age, sex, income, marital status, education,
smoking, tea drinking and other variables, a significant
risk effect for ESCC was found to be associated with the
CYP2C19*2 genotype. Specifically, compared with homo-
zygous GG subjects, carriers of the heterozygous GA and
homozygous AA genotypes had a significantly increased
risk of ESCC (adjusted OR = 2.91, 95% CI: 1.99–4.25 for
GA; adjusted OR = 4.82, 95% CI: 2.84–8.17 for AA) in
an allelic dose–response manner (adjusted PTrend = 0.000).
On pooled analysis, we found that individuals with at least
one copy of the CYP2C19*2 A allele had a 3.19-fold in-
creased risk (adjusted 95% CI: 2.21–4.61, P < 0.001) of
ESCC compared with those without this allele. We found
no significant associations between the CYP2C19*3 geno-
type and ESCC in multivariate logistic regression models.
The association between being a CYP2C19 PM and hav-
ing ESCC was further analyzed. The frequency of CYP2C19
PMs (the genotypes *2/*2 and *2/*3 but not *3/*3 were
found in this study) was significantly higher among the
ESCC patients than in the control group (20.70% vs
13.86%). After adjustment for age, sex, income, marital
status, education, smoking, tea drinking and other vari-
ables, CYP2C19 PMs had a 1.71-fold increased risk of
ESCC compared with EMs.
Possible interactions between CYP2C19 polymorphisms
and environmental factors in ESCC risk
We also explored the combined effects of the CYP2C19*2
polymorphism and certain environmental factors on the
risk of ESCC (Table 5). No significant interactions (multi-
plicative or additive) between CYP2C19*2 and alcohol
drinking, smoking or consumption of fresh vegetables and
fruits were observed. However, the CYP2C19*2 polymorph-
ism appeared to have a multiplicative joint effect with tea
drinking and hot beverage/food consumption (gene–tea
drinking: Pinteraction = 0.042; hot beverage/food consump-
tion: Pinteraction = 6.98 × 10
−6) and an additive joint effect
with pickled vegetable consumption (ICR = 1.96, 95% CI:
0.12–3.80). Specifically, tea drinking may decrease the effect
of the GA/AA genotype on ESCC risk. By contrast, con-
sumption of hot beverages/food or pickled vegetables may
increase the risk effect of the GA/AA genotype.
Discussion
ESCC is prevalent among the Chinese population, with
marked regional variations in incidence and mortality.
Although the pathogenesis of ESCC is not fully elucidated,
accumulative epidemiologic evidence has shown that gen-
etic and environmental factors play crucial roles in its eti-
ology. In the present study, we conducted a case control
study to examine the role of the two most common func-
tional variants of the CYP2C19 gene (CYP2C19*2 and
CYP2C19*3) in the development of ESCC in a Chinese
population, including the effects of environmental risk
Table 2 Association between lifestyle and dietary habits and ESCC risk
Variables Cases Controls Pa Adjusted OR
No % No % (95% CI)b
Smoking1 0.042
No 130 45.61 281 49.30 Reference
Yes 155 54.39 289 50.70 0.194 2.02 (1.10 ~ 3.71)
Pack-years of smoking1
Non-smoker 130 45.61 281 49.30 Reference
<30 56 19.65 124 21.75 0.814 1.54 (0.80 ~ 2.94)
>30 99 34.74 165 28.95 0.034 1.97 (1.05 ~ 3.68)
Alcohol drinking2 0.013
No 220 77.19 451 79.12 Reference
Yes 65 22.81 119 20.88 1.09 (0.70 ~ 1.57)
Tea drinking3 2.99 × 10-9
No 156 54.74 277 48.60
Yes 129 45.26 293 51.40 0.63 (0.45 ~ 0.91)
Hot beverage/food intake4 5.74 × 10-5
No 111 38.95 359 62.98 Reference
Yes 174 61.05 211 37.02 2.95 (2.06~4.22)
Pickled vegetables5
No 135 47.37 355 62.28 5.47 × 10-5 Reference
Yes 150 52.63 215 37.72 1.87 (1.38~2.55)
Fresh vegetables and fruits (g/day)6 0.341
<400 277 97.19 507 88.95 Reference
≥400 8 2.81 63 11.05 0.20 (0.10 ~ 0.44)
Meat (g/day)7 0.016
<200 267 93.68 507 88.95 Reference
≥200 18 6.32 18 3.16 0.75 (0.42 ~ 1.35)
Family history of ESCC8 0.025
No 241 84.56 523 91.75 Reference
Yes 44 15.44 47 8.25 1.77 (1.11 ~ 2.80)
History of reflux esophagitis9 0.026
No 274 96.14 562 98.60 Reference
Yes 11 3.86 8 1.40 2.96 (1.14 ~ 7.67)
aP value based on the Wald test.
bOdds ratio (OR) was determined using logistic regression and age, sex, education, income, marital status, tea drinking, alcohol drinking, smoking, pickled vegetables,
fresh vegetables and fruits, meat, family history of ESCC, history of reflux esophagitis and hot beverage/food intake were included in the multivariate models.
Table 3 SNPs identified for CYP2C19
Nomenclature SNP Nucleotide
changes
Effect MAFa P value for HWF
in ControlsNCBIb Controls Cases P value for association analysisc
CYP2C19*2 (exon5) rs4244285 G681A Splicing defect 0.256 0.335 0.488 2.31 × 10-5 0.09
CYP2C19*3 (exon4) rs4986893 G636A W212X 0.058 0.054 0.040 0.053 0.177
HWE: Hardy–Weinberg equilibrium; MAF: minor allele frequency.
aMajor/minor allele.
bMAF for Chinese in the NCBI dbSNPs database. (http://www.ncbi.nlm.nih.gov/SNP).
cAfter correcting for multiple testing by Haploview software using 1000 permutations.
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rs4244285 GG 59 (20.70) 243 (42.63) 1.00 (Reference) 1.00 (Reference) 6.47 × 10-8
GA 174 (61.05) 272 (47.72) 2.64 (1.87 ~ 3.71) 2.91 (1.99 ~ 4.25) 4.46 × 10-7
AA 52 (18.25) 55 (9.65) 3.89 (2.42 ~ 6.26) 4.82 (2.84 ~ 8.17) 1.21 × 10-6
GA + AA 226 (79.30) 327 (57.37) 2.85 (2.04 ~ 3.96) 3.19 (2.21 ~ 4.61) 2.16 × 10-8
Test for trend 2.08 (1.66 ~ 2.61) 2.30 (1.79 ~ 2.97) 3.17 × 10-8
CYP2C19*3
rs4986893 GG 262 (91.93) 509 (89.30) 1.00 (Reference) 1.00 (Reference) 0.236
GA 23 (8.07) 61 (10.70) 0.73 (0.44 ~ 1.21) 0.72 (0.422 ~ 1.24)
EMs *2/*2,*2/*3 226 (79.30) 491 (86.14) 1.00 (Reference) 1.00 (Reference) 0.009
PMs *1/*1, *1/*2, *1/*3 59 (20.70) 79 (13.86) 1.62 (1.12 ~ 2.35) 1.71 (1.14 ~ 2.57)
n: number of individuals; OR, odds ratio; CI: confidence interval.
aAdjusted for sex, age, education, income, smoking, tea drinking, body mass index and other variables.
bP value based on the Wald test.
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locus in the Chinese population, and multivariable logistic
analysis revealed that the presence of the CYP2C19*2 A
allele (AA or AG genotype) increased the risk of ESCC.
Most of the established risk factors for ESCC evaluated
in the present study had strong associations with ESCC
risk. Generally in case control studies, a potential gene–
environment interaction is assessed; our results show that
the association between the CYP2C19*2 A variant and
ESCC was modified by tea drinking and consumption of
pickled vegetables or hot beverages/food. These findings
suggest that CYP2C19 is involved in the detoxification of
certain carcinogens involved in the development of ESCC.
To our knowledge, this is the first study to report this
gene–environment interaction between environmental
factors and the CYP2C19*2 polymorphism with respect to
the risk of ESCC in a Chinese population.
CYP2C19, one of the most important cytochrome P450s,
is a key enzyme that is not only responsible for the metab-
olism of numerous therapeutic drugs [17-20] but is also
suspected to play a major role in the detoxification or in-
activation of potential carcinogens and the bioactivation
of certain environmental procarcinogens to produce toxic
DNA binding metabolites [8,21]. Therefore, CYP2C19 is
considered an important defense against cancer. The hu-
man CYP2C19 gene is highly polymorphic; the most im-
portant alleles are CYP2C19*2 (681G→A, rs4244285)
and CYP2C19*3 (636G→A, rs4986893). The nucleotide
changes in CYP2C19*2 and *3 lead to a splicing defect
and a stop codon, respectively, and thereby to nonfunc-
tional proteins and the PM phenotype [22]. The two main
enzyme-deficient alleles of CYP2C19 are suspected to be
associated with susceptibility to cancer, though several
studies concerning CYP2C19 polymorphism and cancer
susceptibility among various populations have reportedinconsistent results [23-26]. In the present study, we
found the frequency of CYP2C19*2 to be higher than that
of CYP2C19*3 in Chinese Han subjects and the PM
genotype was associated with an increased risk of ESCC.
This finding is consistent with a recent meta-analysis by
Wang et al. [14], who found an association between the
CYP2C19 PM genotype and increased risk of esophageal
cancer (PM vs EM: OR = 2.93, 95% CI: 2.06–4.17) among
308 cases and 644 controls. However, our single-locus
analysis found a significantly elevated risk of ESCC for the
CYP2C19*2 allele but not for CYP2C19*3. Subjects carry-
ing the CYP2C19*2 A allele (AA or GA genotype) had a
higher risk of ESCC than GG and patients carrying at least
one variant allele had a 3.19-fold increased risk of devel-
oping ESCC. CYP2C19*3 has a premature stop codon in
exon 4 and it is biologically plausible that the CYP2C19*3
polymorphism is a modulator of cancer susceptibility;
however, we did not find CYP2C19*3 to be associated with
ESCC susceptibility in our study population. This finding
is inconsistent with a recent report from Shi et al. [27],
who found that the frequency of the CYP2C19*3 A allele
was significantly higher in ESCC patients than in controls
(5.57% vs 1.86%, P = 0.004). Our current understanding of
carcinogenesis indicates a multifactorial and multistep
process involving various genetic alterations and environ-
mental factors and it is unlikely that risk factors for cancer
act in isolation from each other. Therefore, differences in
certain environmental factors may have contributed to
this discrepancy. For example, Shi et al. [27] found that al-
cohol drinking was a risk factor for ESCC, whereas in the
present study we did not find alcohol to be associated with
ESCC. More importantly, the genetic effects of a SNP may
depend on its interactions with environmental factors.
Therefore, additional studies with a much larger sample
size are warranted to confirm our results. Despite much











Tea drinking 0.04 -1.77 (-3.92 ~ 0.38)
Never GG 25 (8.77) 136 (23.86) Reference
Never GA/AA 104 (36.49) 157 (27.54) 4.17 (2.46 ~ 7.08)
Ever GG 34 (11.93) 107 (18.77) 0.52 (0.32 ~ 0.84)
Ever GA/AA 122 (42.81) 170 (29.82) 1.92 (1.41 ~ 2.63)
Alcohol drinking 0.051 -1.79 (-4.04 ~ 0.46)
Never GG 40 (14.04) 197 (34.56) Reference
Never GA/AA 180 (63.16) 254 (44.56) 3.63 (2.39 ~ 5.51)
Ever GG 19 (6.67) 46 (8.07) 2.32 (1.15 ~ 4.71)
Ever GA/AA 46 (16.14) 73 (12.81) 2.86 (1.60 ~ 5.10)
Smoking 0.48 1.180 (-1.21 ~ 3.57)
Never GG 30 (10.53) 134 (23.51) Reference
Never GA/AA 100 (35.09) 147 (25.79) 3.41 (2.09 ~ 5.57)
Ever GG 29 (10.18) 109 (19.12) 2.23 (1.01 ~ 4.94)
Ever GA/AA 126 (44.21) 180 (31.58) 5.82 (2.80 ~ 12.09)
Intake of fresh fruits and vegetables (g/day) 0.10 1.92 (-5.15 ~ 1.31)
<400 GG 55 (19.30) 212 (37.19) Reference
<400 GA/AA 222 (77.89) 295 (51.75) 2.94 (2.04 ~ 4.24)
≥400 GG 4 (1.40) 31 (5.44) 0.41 (0.134 ~ 1.27)
≥400 GA/AA 4 (1.40) 32 (5.61) 0.43 (0.14 ~ 1.33)
Pickled vegetables 0.12 1.96 (0.12 ~ 3.80)
Never GG 32 (11.23) 150 (26.32) Reference
Never GA/AA 103 (36.14) 205 (35.96) 2.55 (1.61 ~ 4.06)
Ever GG 27 (9.47) 93 (16.32) 1.66 (0.90 ~ 3.04)
Ever GA/AA 123 (43.16) 122 (21.40) 5.17 (3.21 ~ 8.33)
Hot Beverage and food intake 6.98 × 10-6 -0.66 (-6.42 ~ 5.10)
Never GG 12 (4.21) 167 (29.30) Reference
Never GA/AA 99 (34.74) 192 (33.68) 7.64 (3.90 ~ 14.94)
Ever GG 47 (16.49) 76 (13.33) 9.87 (4.67 ~ 20.85)
Ever GA/AA 127 (44.56) 135 (23.68) 15.85 (7.78 ~ 32.30)
aAdjusted for age, sex, education, income, job, marital status, family history of cancer in first degree relatives and other potential confounding factors.
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tors and pathogenic mechanisms in cancer remain a mat-
ter of speculation.
CYP2C19 polymorphism is considered to be one of
the factors that determine an individual’s susceptibility
cancer through variations in ability to detoxify carcino-
gens and/or activate procarcinogens [28,29]. CYP2C19
PM status interacts significantly with environmental risk
factors in modifying susceptibility to squamous cell car-
cinoma of the head and neck [30]. To explore the gene–
environment interaction in ESCC, we investigated the
effects of the CYP2C192 gene and environmental factors
on ESCC risk. Our findings suggest that the CYP2C19*2
polymorphism has a multiplicative joint effect with teadrinking and hot beverage/food consumption and an
additive joint effect with pickled vegetable consumption.
Specifically, consumption of hot beverages/food or pick-
led vegetables may increase the risk effect of the GA/AA
genotype in ESCC. By contrast, tea drinking may de-
crease the risk effect of the GA/AA genotype.
Ecologic studies have shown higher risks of esophageal
and gastric cancers in areas where the consumption of
pickled food is high [31,32]. Consistent with this, our data
show that pickled food consumption was associated with
a 1.76-fold increased risk of ESCC compared with subjects
who did not consume pickled food, and this association
was modified by the presence of CYP2C19*2. In individ-
uals carrying the CYP2C19*2 GA/AA genotype, the risk
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was almost twofold greater than that of those who did
not. The mechanisms by which pickled vegetables and the
CYP2C19*2 polymorphism interact to influence the devel-
opment of ESCC are unknown; however, previous studies
have shown that the traditional method of preparing
pickles by packing moist vegetables in jars for weeks or
months allows fermentation and growth of fungi and
yeasts [33,34] and can potentially yield carcinogenic sub-
stances such as N-nitroso compounds and mycotoxins
[35-37]. Furthermore, polymorphisms in CYP2C19 largely
account for PM status and influence metabolism, particu-
larly detoxification of carcinogens [38]. Therefore, syner-
gism between the CYP2C19*2 polymorphism and pickled
vegetable consumption may be expected.
Numerous experimental and clinical studies have sug-
gested that drinking beverages at high temperatures is a
cause of esophageal cancer [39,40]. More tumors were
observed and the size of esophageal papillomas was in-
creased at temperatures of 70°C and above in a previous
experimental study [41]. Consistent with this, our data
show that drinking beverages at high temperatures was a
risk factor for ESCC. Notably, we found significant syn-
ergism between consumption of hot beverages/food and
the CYP2C19*2 polymorphism. The mechanisms by
which drinking beverages at high temperatures and the
CYP2C19*2 polymorphism interact to influence the de-
velopment of ESCC are unknown and additional studies
are warranted to explain and confirm this preliminary
evidence.
The results of the present study also suggest possible
interactions between tea drinking and the CYP2C19*2
polymorphism. Among individuals with the CYP2C19*2
GA/AA genotype, the risk of ESCC in tea non-drinkers
was almost twice that in tea drinkers. Polyphenols in tea
possess potent antioxidant and anti-inflammatory proper-
ties and modulate several signaling pathways, and these
biochemical features are responsible for tea’s anticancer
properties [42,43]. Previous studies have reported that
green tea protects against cancers caused by various envir-
onmental carcinogens [43-45]. CYP2C19 is involved in the
metabolism of many carcinogens; therefore, our results sug-
gest that consumption of tea might have a potential ESCC
prevention benefit in individuals with the CYP2C19*2
GA/AA genotype. Intervention trials are needed to pro-
vide more convincing evidence.
The potential limitations of the present study should
be considered. First, this was a hospital-based case control
study and selection bias may exist because the control
subjects were recruited from a healthy population under-
going an examination, which may not accurately represent
a geographically matched population with exposure to
similar environmental factors. However, the control sub-
jects came from the same region as the patients and weresampled randomly, which may have reduced the selection
bias. Second, recall bias is inevitable in case control stud-
ies. However, this would not affect the genotype data and
is therefore of less concern in the study of gene–disease
associations. Finally, the selected CYP2C19 polymorphism
is a single example that was previously reported to have
potential functional significance. Further studies of add-
itional SNPs of functional significance are warranted to
identify the role of CYP2C19 polymorphism and gene–
environment interactions in esophageal carcinogenesis.
Conclusions
In summary, our findings suggest that the CYP2C19*2 A
allele (AA or AG genotype) plays an important role in
the development of ESCC in the Chinese population. In
addition, our results show that the association between
the CYP2C19*2 A variant and ESCC was modified by tea
drinking and consumption of pickled vegetables or hot
beverages/food. Since our study has limited sample size,
further studies in a large population are needed to con-
firm these findings.
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